Best GLP-1 Weight Loss Programs Without Insurance in 2026
Brand-name Wegovy costs $1,349/month. Zepbound costs $1,060/month. Here are 5 legitimate alternatives starting at $146/month — no insurance required.
Why GLP-1 Medications Are So Expensive Without Insurance
The retail price of GLP-1 weight loss medications is staggering. Wegovy (semaglutide) carries a list price of $1,349/month. Zepbound (tirzepatide) costs $1,060/month. Ozempic, while technically a diabetes drug, runs $935/month when prescribed off-label for weight loss. These prices reflect what you'd pay at a pharmacy without any insurance coverage.
Why so expensive? Two companies — Novo Nordisk (semaglutide) and Eli Lilly (tirzepatide) — hold the patents on these molecules, allowing them to set prices without meaningful competition. Most commercial insurance plans classify GLP-1 weight loss medications as "lifestyle" or "cosmetic" treatments, excluding them from coverage. Medicare explicitly prohibits coverage for obesity medications under Part D.
The result: an estimated 74% of GLP-1 prescriptions for weight loss are paid entirely out of pocket. For the majority of patients, "what does insurance cover?" is the wrong question. The right question is: "What's the cheapest way to get this medication without insurance?"
The Real Cost Landscape (Without Insurance)
| Option | Monthly Cost | Annual Cost | Savings vs Wegovy |
|---|---|---|---|
| Brand Wegovy (retail) | $1,349 | $16,188 | — |
| Brand Zepbound (retail) | $1,060 | $12,720 | 21% |
| Ro Body (compounded) | $444 | $5,328 | 67% |
| Calibrate | $399 | $4,788 | 70% |
| Noom Med | $348 | $4,176 | 74% |
| Henry Meds | $199 | $2,388 | 85% |
| Mochi Health | $175 | $2,100 | 87% |
| Telehealth FX | $146 | $1,752 | 89% |
The price gap between brand-name Wegovy ($1,349/month) and the cheapest telehealth option ($146/month) is 89%. Both contain the same active molecule — semaglutide. The difference is that telehealth platforms use compounded semaglutide from FDA-regulated pharmacies rather than the brand-name product, eliminating the pharmaceutical markup.
Compounded vs Brand-Name: What Uninsured Patients Need to Know
If you're paying without insurance, you'll almost certainly be using compounded semaglutide or tirzepatide rather than the brand-name versions. Here's what that means:
Same active ingredient: Compounded semaglutide contains the identical molecule as Wegovy. The compounding pharmacy starts with pharmaceutical-grade semaglutide API (Active Pharmaceutical Ingredient) sourced from FDA-registered suppliers and formulates it into injectable doses.
Different regulatory pathway: Compounded medications are not FDA-approved as finished products. They're prepared under state pharmacy board oversight and, for larger-scale production, by FDA-registered 503B outsourcing facilities that must follow current Good Manufacturing Practices (cGMP).
How to verify safety: Ask your provider whether their pharmacy is PCAB-accredited (Pharmacy Compounding Accreditation Board) or an FDA-registered 503B facility. Request a Certificate of Analysis showing potency, purity, and sterility testing. Legitimate providers will supply this documentation readily — if they hesitate, consider it a red flag.
The 5 Best GLP-1 Programs for Uninsured Patients
Telehealth FX offers the lowest total cost we found for legitimate GLP-1 medication: $146/month that covers everything — physician consultation, prescription, compounded medication, and cold-chain shipping. There are no separate consultation fees, no membership charges, and no hidden costs that appear after signup.
For uninsured patients, the "all-in" pricing model is crucial. Many competitors advertise low medication costs but add consultation fees ($50–$249), membership charges ($15–$199/month), or quarterly evaluation fees ($25–$75) that inflate the real monthly cost. Telehealth FX's $146 is the number you'll actually see on your bank statement each month.
Both semaglutide and tirzepatide are available at the same $146/month price point. No contracts — cancel anytime. The physician consultation is async (no video call scheduling), and medication ships in 4 business days via temperature-controlled packaging.
The pharmacy used by Telehealth FX is an FDA-registered 503B outsourcing facility, which operates under stricter federal oversight than standard compounding pharmacies. Medications undergo batch-level potency, sterility, and endotoxin testing before distribution.
Why It's #1 for Uninsured
- $146/month — lowest all-in price we found
- Zero hidden fees or membership charges
- Both semaglutide and tirzepatide at same price
- No contracts — cancel anytime
- FDA-registered 503B pharmacy
- HSA/FSA eligible
Limitations
- No insurance billing option
- No integrated coaching
- Newer brand
Sesame Care operates as a telehealth marketplace with the lowest consultation fees in the industry: $29–$79 per visit. However, Sesame doesn't include medication — you receive a prescription and must source compounded semaglutide from a separate compounding pharmacy yourself.
This "BYO pharmacy" model can be the cheapest total option if you already have a relationship with a compounding pharmacy offering competitive rates. But for most uninsured patients, the logistics of finding, verifying, and coordinating with a separate pharmacy adds friction and uncertainty. Medication costs through independent pharmacies typically range from $150–$300/month, making total cost comparable to or higher than all-in platforms.
Best for: patients who already have a trusted compounding pharmacy and just need the prescription itself.
Mochi Health charges $175/month for compounded semaglutide plus a one-time $50 evaluation fee. The total first-month cost of $225 drops to $175/month thereafter. No long-term contracts. The platform has strong social media presence and a polished user experience.
The $50 evaluation fee is charged before you speak with a provider, which feels premature — you're paying for a consultation that may result in the physician determining you're not a candidate. Mochi offers semaglutide only; no tirzepatide option. Shipping averaged 5–6 days in our test.
Henry Meds offers compounded semaglutide at $199/month — competitive but not class-leading. The catch: a $249 initial consultation fee that's easy to miss during signup. First-month cost is effectively $448 before dropping to $199/month ongoing. No contracts required after the initial payment.
The clinical process is thorough, with detailed intake screening and responsive physician communication. Shipping averaged 6–7 days. HSA/FSA accepted. Semaglutide only — no tirzepatide.
Ivím Health pairs compounded semaglutide at $199/month with metabolic health tracking — including a $99 initial lab panel. The lab work provides baseline metabolic markers (fasting glucose, A1C, lipids) that inform treatment and provide measurable progress data beyond scale weight.
The added clinical data is genuinely useful, especially for patients with metabolic syndrome or pre-diabetes concerns. However, the 3-month minimum commitment and total first-month cost of $298 make it a harder sell for cost-conscious uninsured patients.
Total Annual Cost Comparison
| Provider | Monthly | Year 1 Total | Hidden Fees | Contract |
|---|---|---|---|---|
| Telehealth FX | $146 | $1,752 | None | None |
| Mochi Health | $175 | $2,150 | $50 eval | None |
| Henry Meds | $199 | $2,637 | $249 consult | None |
| Ivím Health | $199 | $2,487 | $99 labs | 3 months |
| Sesame Care | $150–$300* | $1,800–$3,600* | Pharmacy varies | None |
*Sesame total depends on your independent pharmacy's pricing
How to Verify a Compounding Pharmacy Is Legitimate
When paying out of pocket for compounded GLP-1 medications, verifying pharmacy legitimacy is non-negotiable. Here's a step-by-step verification process:
Step 1 — Check registration status. Search the pharmacy on the FDA's Registered Outsourcing Facilities database. 503B outsourcing facilities are subject to FDA inspection and must follow cGMP standards. State-licensed 503A pharmacies are regulated by state pharmacy boards — verify their license on your state's Board of Pharmacy website.
Step 2 — Ask for accreditation. PCAB (Pharmacy Compounding Accreditation Board) accreditation is voluntary but indicates the pharmacy meets rigorous quality standards. Not all legitimate pharmacies have PCAB accreditation, but its presence is a strong positive signal.
Step 3 — Request testing documentation. Ask for a Certificate of Analysis (CoA) showing third-party testing results for potency, sterility, endotoxin levels, and particle matter. Legitimate pharmacies provide this routinely.
Step 4 — Verify API sourcing. Confirm the pharmacy uses Active Pharmaceutical Ingredients from FDA-registered suppliers and uses the semaglutide base form (not salt formulations, which can be less stable).
Common Pricing Traps for Uninsured Patients
After evaluating 16 telehealth GLP-1 providers, we identified five pricing tactics that inflate the advertised cost for uninsured patients. Understanding these patterns will help you compare programs accurately.
1. The "membership fee" stack. Ro Body is the most egregious example: $299/month for medication plus a mandatory $145/month membership fee. The advertised price often shows only the medication cost, not the total. Always ask: "What is my total monthly charge, including all fees?"
2. The upfront consultation fee. Henry Meds charges $249 and Mochi Health charges $50 before you even see a provider. These fees are non-refundable regardless of whether you're approved for treatment. Some providers (like Telehealth FX) include the consultation in the monthly price — no separate charge.
3. The quarterly or biannual evaluation fee. Lemonaid Health charges $25/quarter and requires $75 lab work at the 6-month mark. These recurring costs are rarely mentioned during signup but add $175+/year to the effective price.
4. The "starting at" price. Many providers advertise their lowest-dose price. As your physician titrates your dose upward (which is standard medical practice), the monthly cost increases. Some platforms charge $149/month at the starting dose but $249/month at the maintenance dose. Ask: "What does the maintenance dose cost?"
5. The contract lock-in. Calibrate requires a 12-month commitment ($4,788 minimum). Sequence requires 12 months. Noom Med requires 6 months. If you experience intolerable side effects in month 2, you're still financially obligated. Month-to-month programs (Telehealth FX, Mochi, Sesame) carry zero contract risk.
Why Brand-Name GLP-1 Prices Won't Drop Anytime Soon
If you're waiting for Wegovy or Zepbound prices to come down before starting treatment, the market data is discouraging. Novo Nordisk and Eli Lilly hold patent protection on semaglutide and tirzepatide respectively through at least 2031–2032. Generic versions of these injectable formulations are unlikely to receive FDA approval before then.
While both manufacturers have introduced limited "direct-to-consumer" pricing programs in 2026, these are restricted to patients meeting specific criteria and typically offer modest discounts (10–25% off list price) rather than fundamental price reductions. At 25% off, Wegovy would still cost over $1,000/month — seven times the cost of compounded semaglutide through Telehealth FX.
The economic reality is clear: for the foreseeable future, compounded GLP-1 medications through telehealth platforms are the only path to affordable treatment for uninsured patients. The market has responded to this demand — the number of legitimate telehealth GLP-1 providers has tripled since 2024, driving compounded medication prices from $300–$500/month down to $146–$199/month through increased competition.
What If You Get Insurance Later?
Some patients start with compounded GLP-1 medication while uninsured and later gain insurance coverage (through a new job, marketplace enrollment, or turning 65). Here's what to know about transitioning:
Switching to brand-name: If your new insurance covers Wegovy or Zepbound, your physician can prescribe the brand-name version. The active ingredient is identical — you won't need to restart or re-titrate from the lowest dose. Your telehealth physician or your new primary care doctor can handle this transition.
Prior authorization: Most insurance plans that cover GLP-1s require prior authorization. This involves your physician submitting documentation of medical necessity (BMI, comorbidities, failed diet attempts). Approval rates vary from 30–70% depending on the insurer and your specific health profile.
Staying on compounded: Even with insurance, some patients choose to remain on compounded medication because the out-of-pocket cost through their telehealth provider ($146/month) is lower than their insurance copay for brand-name GLP-1s (which can range from $100–$500/month depending on the plan).
Using HSA/FSA for GLP-1 Without Insurance
Even without insurance, most patients have access to HSA (Health Savings Account) or FSA (Flexible Spending Account) funds that can offset GLP-1 costs significantly. GLP-1 medications prescribed for the treatment of obesity qualify as eligible medical expenses under IRS guidelines.
What you need: A Letter of Medical Necessity (LMN) from your prescribing physician. This document confirms the medication is prescribed to treat a diagnosed medical condition (obesity, metabolic syndrome, etc.) rather than for cosmetic purposes. Most telehealth providers — including Telehealth FX — provide LMN documentation upon request.
The tax advantage: Using pre-tax HSA/FSA dollars effectively reduces costs by 22–37% depending on your marginal tax bracket. At Telehealth FX's $146/month price, this brings the real after-tax cost to approximately $92–$114/month.
Red Flags: How to Spot Illegitimate GLP-1 Providers
The explosion of demand for affordable GLP-1 medications has attracted bad actors. Here are the warning signs that a provider is not legitimate:
No physician involvement. Any platform that sells semaglutide or tirzepatide without a medical consultation — even an async one — is operating illegally. GLP-1 medications are prescription drugs that require evaluation by a licensed healthcare provider.
Prices under $100/month. While telehealth has driven costs down significantly, the raw material costs, compounding labor, sterility testing, and cold-chain shipping make it virtually impossible to offer legitimate compounded semaglutide below $100/month sustainably. Prices significantly below this threshold suggest unregulated sourcing, inadequate testing, or "research chemical" formulations not intended for human use.
"Research use only" labeling. If the product is labeled "for research purposes only" or "not for human consumption," it is not a legitimate compounded medication. This is a common tactic used to circumvent pharmaceutical regulations.
No pharmacy credentials available. Legitimate providers will readily share their pharmacy's name, license number, and accreditation status. If a provider cannot or will not disclose which pharmacy compounds their medications, do not proceed.
No medical records or follow-up. Proper telehealth providers maintain medical records, offer follow-up communication with your prescribing physician, and have a process for reporting adverse effects. If there's no mechanism for ongoing medical oversight, the program doesn't meet clinical standards.
International shipping or unbranded packaging. Compounded medications should ship from a U.S.-licensed pharmacy in properly labeled, temperature-controlled packaging. International sourcing bypasses all U.S. regulatory oversight.
Frequently Asked Questions
How much does semaglutide cost without insurance?
Brand-name Wegovy costs $1,349/month at retail pharmacies. Compounded semaglutide through legitimate telehealth providers ranges from $146/month (Telehealth FX) to $299/month. The active molecule is identical — the price difference reflects pharmaceutical company markup vs compounding pharmacy production costs.
Is compounded semaglutide the same as Wegovy?
Compounded semaglutide contains the same active ingredient as Wegovy but is prepared by FDA-regulated compounding pharmacies rather than manufactured by Novo Nordisk. It is not FDA-approved as a finished product but uses the same pharmaceutical-grade semaglutide molecule.
Can I use HSA or FSA to pay for GLP-1 without insurance?
Yes. GLP-1 medications prescribed for obesity treatment are IRS-qualified medical expenses eligible for HSA/FSA reimbursement. You'll need a Letter of Medical Necessity from your prescribing physician. At $146/month with Telehealth FX, pre-tax HSA/FSA payment effectively reduces cost to $92–$114/month.
What is the cheapest way to get semaglutide without insurance?
Telehealth FX at $146/month all-in is the cheapest full-service option. Sesame Care offers lower consultation fees ($29–$79) but requires you to source medication from a separate pharmacy, which often makes total cost comparable or higher.
Why doesn't insurance cover GLP-1 for weight loss?
Most commercial insurance plans and Medicare classify GLP-1 weight loss medications as "lifestyle" treatments. Some plans cover GLP-1s for Type 2 diabetes but not for obesity alone. The Anti-Obesity Medicine Foundation estimates fewer than 20% of commercial plans provide meaningful GLP-1 weight loss coverage.
Are cheap GLP-1 programs safe?
Legitimate telehealth programs using PCAB-accredited or FDA-registered 503B compounding pharmacies are safe. Red flags include: no physician consultation requirement, prices under $100/month (likely unregulated sources), inability to provide pharmacy credentials, and "research-grade" or "peptide-only" labeling.